Hayashi Y - Search Results

1

O-N intramolecular acyl migration strategy in water-soluble prodrugs of taxoids.

Skwarczynski M, Sohma Y, Kimura M, Hayashi Y, Kimura T, Kiso Y. Skwarczynski M, et al. Among authors: hayashi y. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4441-4. doi: 10.1016/j.bmcl.2003.09.020. Bioorg Med Chem Lett. 2003. PMID: 14643342

2

Focus tonsils and skin diseases with special reference to palmoplantar pustulosis.

Kuki K, Kimura T, Hayashi Y, Tabata T. Kuki K, et al. Among authors: hayashi y. Adv Otorhinolaryngol. 1992;47:196-202. doi: 10.1159/000421744. Adv Otorhinolaryngol. 1992. PMID: 1280904 No abstract available.

3

Inhibition by vanadyl of adenylate cyclase activation reactions in rat adrenal membranes.

Hayashi Y, Kimura T. Hayashi Y, et al. Biochem Biophys Res Commun. 1985 Aug 15;130(3):945-51. doi: 10.1016/0006-291x(85)91706-1. Biochem Biophys Res Commun. 1985. PMID: 2992510

4

The effects of vanadium compounds on the activation of adenylate cyclase from rat adrenal membrane.

Hayashi Y, Kimura T. Hayashi Y, et al. Biochim Biophys Acta. 1986 Jan 17;869(1):29-36. doi: 10.1016/0167-4838(86)90306-7. Biochim Biophys Acta. 1986. PMID: 3002477

5

Vanadium inhibits ACTH-mediated but not cyclic AMP-dependent adrenal steroidogenesis.

Hayashi Y, Kimura T. Hayashi Y, et al. Mol Cell Endocrinol. 1986 Jan;44(1):17-24. doi: 10.1016/0303-7207(86)90101-2. Mol Cell Endocrinol. 1986. PMID: 3005081

6

'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.

Matsumoto H, Hamawaki T, Ota H, Kimura T, Goto T, Sano K, Hayashi Y, Kiso Y. Matsumoto H, et al. Among authors: hayashi y. Bioorg Med Chem Lett. 2000 Jun 5;10(11):1227-31. doi: 10.1016/s0960-894x(00)00202-x. Bioorg Med Chem Lett. 2000. PMID: 10866387

7

New water-soluble prodrugs of HIV protease inhibitors based on O-->N intramolecular acyl migration.

Hamada Y, Ohtake J, Sohma Y, Kimura T, Hayashi Y, Kiso Y. Hamada Y, et al. Among authors: hayashi y. Bioorg Med Chem. 2002 Dec;10(12):4155-67. doi: 10.1016/s0968-0896(02)00322-x. Bioorg Med Chem. 2002. PMID: 12413869

8

An expedient synthesis of N(alpha)-protected-L-tetrahydrofuranylglycine and its application in the synthesis of novel substrate based inhibitors of HIV-1 protease.

Rajesh S, Ami E, Kotake T, Kimura T, Hayashi Y, Kiso Y. Rajesh S, et al. Among authors: hayashi y. Bioorg Med Chem Lett. 2002 Dec 16;12(24):3615-7. doi: 10.1016/s0960-894x(02)00781-3. Bioorg Med Chem Lett. 2002. PMID: 12443788

9

Design and synthesis of pseudo-symmetric HIV protease inhibitors containing a novel hydroxymethylcarbonyl (HMC)-hydrazide isostere.

Hidaka K, Kimura T, Hayashi Y, McDaniel KF, Dekhtyar T, Colletti L, Kiso Y. Hidaka K, et al. Among authors: hayashi y. Bioorg Med Chem Lett. 2003 Jan 6;13(1):93-6. doi: 10.1016/s0960-894x(02)00848-x. Bioorg Med Chem Lett. 2003. PMID: 12467624

10

Effect of the acyl groups on O-->N acyl migration in the water-soluble prodrugs of HIV-1 protease inhibitor.

Hamada Y, Matsumoto H, Kimura T, Hayashi Y, Kiso Y. Hamada Y, et al. Among authors: hayashi y. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2727-30. doi: 10.1016/s0960-894x(03)00576-6. Bioorg Med Chem Lett. 2003. PMID: 12873502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,260 results

Search Page

Filters